iShares Biotechnology ETF (NASDAQ:IBB) Position Reduced by Perkins Coie Trust Co

Perkins Coie Trust Co decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 2.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,446 shares of the financial services provider’s stock after selling 738 shares during the period. Perkins Coie Trust Co’s holdings in iShares Biotechnology ETF were worth $3,559,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the business. Royal Fund Management LLC acquired a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at about $1,304,000. WealthCare Investment Partners LLC increased its holdings in iShares Biotechnology ETF by 2.8% in the third quarter. WealthCare Investment Partners LLC now owns 10,252 shares of the financial services provider’s stock worth $1,458,000 after buying an additional 281 shares during the last quarter. Marion Wealth Management increased its holdings in iShares Biotechnology ETF by 4.3% in the third quarter. Marion Wealth Management now owns 19,221 shares of the financial services provider’s stock worth $2,799,000 after buying an additional 792 shares during the last quarter. KWB Wealth increased its holdings in iShares Biotechnology ETF by 8.6% in the third quarter. KWB Wealth now owns 4,145 shares of the financial services provider’s stock worth $569,000 after buying an additional 329 shares during the last quarter. Finally, Thrive Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the third quarter worth approximately $445,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.1 %

IBB stock traded down $0.14 during midday trading on Wednesday, hitting $142.86. 78,110 shares of the company traded hands, compared to its average volume of 1,479,026. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.57. The business has a 50 day simple moving average of $145.27 and a 200-day simple moving average of $139.22.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.